NCT00442598 2015-03-10Safety and Efficacy Study of Glufosfamide in Ovarian CancerEleison Pharmaceuticals LLC.Phase 2 Terminated17 enrolled 9 charts
NCT00435578 2009-04-30Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung CarcinomaThreshold PharmaceuticalsPhase 2 Terminated50 enrolled